-
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Effects of zinc and multimineral vitamin supplementation on glycemic and lipid control in adult diabetes
Original Research
(2300) Views (754) Full article downloads
Authors: Priyanka Gunasekara, Manjula Hettiarachchi, Chandrani Liyanage, et al
Published Date January 2011
Volume 2011:4 Pages 53 - 60
DOI: http://dx.doi.org/10.2147/DMSO.S16691
Priyanka Gunasekara1, Manjula Hettiarachchi2, Chandrani Liyanage2, Sarath Lekamwasam21Coronary Care Unit, Teaching Hospital, Karapitiya, Galle, Sri Lanka; 2Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka
Aims: To evaluate the effects of zinc with or without other antioxidants on blood glucose, lipid profile, and serum creatinine in adult diabetics on long-term follow-up.
Materials and methods: Patients (n = 96) were randomly allocated to three groups: group A (n = 29) was supplemented with oral zinc sulfate (22 mg/day) and multivitamin/mineral (zinc+MVM) preparation; group B (n = 31) was given the same preparation without zinc (MVM); and group C (n = 36) was given a matching placebo for a period of 4 months in a single-blinded study. Blood samples were taken at baseline and after 4 months of supplementation to assess blood glucose (fasting and postprandial) and glycosylated hemoglobin (HbA1C%) and serum levels of zinc, creatinine, and lipids.
Results: The zinc+MVM group had a mean change of fasting blood sugar -0.33 mmol/L (standard error of the mean 0.21 mmol/L) and was significant (P = 0.05) when compared with the other two groups (mean change in the MVM group +0.19 (0.31) mmol/L and +0.43 (0.23) mmol/L in the control group, respectively). The HbA1C% level reduced significantly, irrespective of the baseline level, in zinc+MVM-supplemented individuals. In the other two groups, the change of HbA1C% level was not significant. Serum lipid levels reduced significantly in the zinc+MVM and MVM groups.
Conclusions: Zinc+MVM supplementation showed beneficial effects in the metabolic control of adult diabetics in addition to elevating their serum zinc level. Zinc supplementation improved glycemic control measured by HbA1C% and fasting and postprandial glucose. Furthermore, zinc supplementation lowered serum cholesterol and cholesterol/high-density lipoprotein ratio.
Keywords: zinc, multivitamin mineral supplementation, diabetes, glycemic control
Readers of this article also read:
Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
Lifestyle modification in the management of the metabolic syndrome: achievements and challenges
Serum ferritin concentration in gestational diabetes mellitus and risk of subsequent development of early postpartum diabetes mellitus
Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
Treating statin-intolerant patients
Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes
Is vitamin D status a determining factor for metabolic syndrome? A case-control study
Update on the management of diabetic polyneuropathies
Obesity: considerations about etiology, metabolism, and the use of experimental models
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- The economic impact of obesity in the United States
- Alogliptin: a new addition to the class of DPP-4 inhibitors
- Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
- Adipose inflammation: cause or consequence of obesity-related insulin resistance




